tert-butyl (3RS,4RS)-4-(5-benzyloxy-pyrimidin-2-yl)-3-hydroxy-piperidine-1-carboxylate → tert-butyl (3RS,4RS)-3-hydroxy-4-(5-hydroxy-pyrimidin-2-yl)-piperidine-1-carboxylate

HRID 1005216Notes

Reaction equation

HRID 1005216 reaction equation
C([O:8][C:9]1[CH:10]=[N:11][C:12]([CH:15]2[CH2:20][CH2:19][N:18]([C:21]([O:23][C:24]([CH3:27])([CH3:26])[CH3:25])=[O:22])[CH2:17][CH:16]2[OH:28])=[N:13][CH:14]=1)C1C=CC=CC=1>CO.[Pd]>[OH:28][CH:16]1[CH:15]([C:12]2[N:13]=[CH:14][C:9]([OH:8])=[CH:10][N:11]=2)[CH2:20][CH2:19][N:18]([C:21]([O:23][C:24]([CH3:27])([CH3:26])[CH3:25])=[O:22])[CH2:17]1

Participants

4

Procedure

A solution of 110 mg (0.29 mmol) of tert-butyl (3RS,4RS)-4-(5-benzyloxy-pyrimidin-2-yl)-3-hydroxy-piperidine-1-carboxylate in 5 ml of methanol was treated with 20 mg of 5% palladium-charcoal and hydrogenated at room temperature for 12 hours. For the working-up, the catalyst was filtered off and washed with 20 ml of methanol. The methanol solution was evaporated under reduced pressure and the resulting oil was crystallized by the addition of ether. There were obtained 80 mg (93% of theory) of tert-butyl (3RS,4RS)-3-hydroxy-4-(5-hydroxy-pyrimidin-2-yl)-piperidine-1-carboxylate in the form of colourless, slightly delequesent crystals; MS: 296 (M+H)+.

Workup

  1. filtrationthe catalyst was filtered off
  2. washwashed with 20 ml of methanol
  3. customThe methanol solution was evaporated under reduced pressure
  4. customthe resulting oil was crystallized by the addition of ether

Sources & evidence

ORD record
ord-25f1aa4243dc4bafbec1915f33666766
Source dataset
uspto-grants-2000_04
Patent number
US06051712

Reaction notes

Loading…